Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
China SXT Pharmaceuticals, Inc., a pharmaceutical company, is engaged in the research, development, manufacture, marketing and sale of Traditional Chinese Medicine Tablets (TCMP) in China. The company is headquartered in Taizhou, China.
52W High
$5.70
52W Low
$0.30
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.36
Valuation
As of 2024-12-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.36
EV/Revenue (<3 favorable)
97.47
P/S (TTM) (<3 favorable)
107.30
P/B (<3 favorable)
12.10
Ownership
Retail‑heavySource: Overview
Insiders (1–5% typical)
35.33%
Institutions (25–75% balanced)
0.07%
Shares Outstanding
116,028,000
Float
75,031,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2024-12-31 (Overview)
Revenue (TTM)
1,740,900
Gross Profit (TTM)
367,430
EPS (TTM)
-2.32
Profit Margin (>10% good)
-1.90%
Operating Margin (TTM) (higher better)
-2.24%
ROE (TTM) (>15% strong)
-0.23%
EPS YoY (Quarterly) (>10% good)
0.43
Revenue YoY (Quarterly) (>8% good)
-0.08
Momentum
Value
N/A
Previous
N/A
Trend
—
Signal Cross
No cross
As of
—